Output details
1 - Clinical Medicine
University of Manchester
Return to search
Output 0 of 0 in the submission
Article title
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma.
Type
D - Journal article
Title of journal
Clinical Cancer Research
Article number
-
Volume number
16
Issue number
3
First page of article
1042
ISSN of journal
1078-0432
Year of publication
2010
URL
-
Number of additional authors
9
Additional information
The author made a substantial contribution to carrying out the study and analysis and interpretation of study data. The author helped critique the output.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
66
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-